AXGN Q1 2020 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+4.2% YoY

Gross Profit

$19M80.1% margin

Operating Income

-$9M-35.1% margin

Net Income

-$8M-33.8% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-13.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$13M

Stock-Based Comp.

$556,000

Balance Sheet

Total Assets

$145M

Total Liabilities

$21M

Stockholders' Equity

$124M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$23M	+4.2%
Gross Profit	$19M	$20M	-0.6%
Operating Income	-$9M	-$10M	+16.6%
Net Income	-$8M	-$10M	+13.8%